Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

49.92 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 13, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
86 87 Next >
Pfizer Fails To Boost Its 2022 Outlook, And Shares Pay The Price
Analysts had overly bullish sales views, and Pfizer doesn't think it can meet them. 
Via Investor's Business Daily
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Pfizer Posts Street Beating Q1 Earnings, Revises FY22 Profit Outlook
 
Via Benzinga
Pfizer: Q1 Earnings Insights
Pfizer (NYSE:PFE) reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:45 AM. Here's what investors need to know about the announcement. Earnings Pfizer beat estimated earnings by 8.0%,... 
Via Benzinga
Protalix PRX-102: Likely Approval Could Be A Game Changer
Protalix's PRX-102 drug stands a good chance of being accepted against Fabry disease, with three P3 trials delivering good results. 
Via Talk Markets
Pfizer's COVID-19 Antiviral Pill Fails To Prevent Post Exposure Infection In Household Members
 
Via Benzinga
FDA Gives Green Signal To Pfizer's Duchenne Gene Therapy Trial
 
Via Benzinga
Pfizer Reports First-Quarter 2022 Results
From Pfizer Inc.
Via Business Wire
A Peek Into The Markets: US Stock Futures Flat Ahead Of FOMC Meeting
Pre-open movers 
Via Benzinga
5 Stocks To Watch For May 3, 2022
Some of the stocks that may grab investor focus today are: 
Via Benzinga
Record Trade Deficit Contracts Economy
The equity market struggled again last week as the S&P 500 saw its fourth consecutive weekly loss. The U.S housing market continues to run hot as single-family home prices and price appreciation have... 
Via Talk Markets
4 Top Stock Trades for Tuesday: PFE, MOS, EXPE, UBER
Pfizer, Mosaic and Expedia are due to report earnings, while Uber is flirting with a retest of the lows. Here are our top stock trades now. 
Via InvestorPlace
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Check Out What Whales Are Doing With PFE
A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 16 strange trades. 
Via Benzinga
Moderna Bullish On COVID-19 Vaccine For Younger Kids To Be Ready Next Month: Reuters
 
Via Benzinga
Monday's Market Minute: Three Things To Know About The Week Ahead
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
April's Sell-Off Continues Into May As Futures Point To A Lower Open
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
3 High-Quality Stocks to Buy During This Market Selloff
When the markets are roiling and uncertain, high-quality stocks like BLDR, ANTM and PFE can help investors ride out the troubled times. 
Via InvestorPlace
Disappointing Earnings And A Spike In Inflation Send Stocks Plunging
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks... 
Via Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, May 2
CNBC Fourth COVID-19 Shot? See Why Medical Professionals Are Skeptical Medical professionals are undecided on whether a fourth dose of the Covid-19 vaccine would benefit the... 
Via Benzinga
Fourth COVID-19 Shot? See Why Medical Professionals Are Skeptical
Medical professionals are undecided on whether a fourth dose of the Covid-19 vaccine would benefit the wider population, as countries are beginning to offer the fourth dose to vulnerable groups. 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
The month of April was a mixed one for regulatory approvals. The Food and Drug Administration delayed approvals for at least three treatment candidates. New molecular entity, or NME, approvals, a... 
Via Benzinga
7 Stocks Reporting Earnings the Week of May 2
The earnings train rolls on with first quarter financial results from several prominent blue-chip companies over the next week. 
Via InvestorPlace
4 Healthcare Funds With "Double Discounts"
There's nothing that closed-end fund investors love more than finding a smartly run fund in an unfairly beaten-down sector. This hands us a nice discount plus a much bigger dividend. Let's take a look... 
Via Talk Markets
This Is What Whales Are Betting On Pfizer
A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 17 strange trades. 
Via Benzinga
FDA Sets Review Dates For Pfizer, Moderna COVID-19 Shot For Kids, Plus Novavax EUA
 
Via Benzinga
Novavax Surges As Its Covid Shot Approaches The FDA Finish Line
The FDA advisory committee will meet June 7 to discuss its Covid shot. 
Via Investor's Business Daily
How is it going with the Big Biopharma Earnings Week?
Abbott and JNJ kicked off healthcare earnings last week and the results were just OK. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
86 87 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.